Supplemental Cash Flow Information (Tables)

12 Months Ended

Dec. 31, 2023

Supplemental Cash Flow Elements [Abstract]

Summary of Supplemental Cash Flow Information

The following table provides supplemental cash flow information (in thousands):

	Year Ended December 31,
	2023		2022		2021
Supplemental cash flow information:
Interest paid	$	5,798	$	3,672	$	4,824
Income taxes paid (refunded), net	5,359		5,313		1,819
Supplemental disclosure of non-cash financing activities:
Reclassification of contingently redeemable common stock in connection with IPO	—		—		309,500
Issuance of common stock under partner physician group equity agreements upon IPO	—		—		268,467
Offering costs accrued at end of period	—		—		295
Non-cash investment in unconsolidated subsidiaries	—		190		763

Summary of Restricted Cash Equivalents from Continuing Operations

The following table summarizes cash, cash equivalents and restricted cash equivalents from continuing operations (in thousands):

	December 31,
	2023		2022
Cash and cash equivalents	$	107,570	$	465,302
Restricted cash and equivalents	6,759		10,610
Cash, cash equivalents and restricted cash equivalents	$	114,329	$	475,912

Schedule of Cash and Cash Equivalents from Continuing Operations

The following table summarizes cash, cash equivalents and restricted cash equivalents from continuing operations (in thousands):

	December 31,
	2023		2022
Cash and cash equivalents	$	107,570	$	465,302
Restricted cash and equivalents	6,759		10,610
Cash, cash equivalents and restricted cash equivalents	$	114,329	$	475,912